European Innovation Council

Developer of computing software intended to speed up the process of physical verification of integrated circuits (ICs). The company researches and creates technologies and software that integrate advanced parallel computing, accelerate machine simulations, and automate circuit verification, enabling clients to ramp up their IC design and verification process, deliver custom IP, and ensure bug-free silicon.

embotech AG specializes in developing decision-making software solutions for autonomous systems. Founded in 2013 as a spin-off from the Automatic Control Laboratory at ETH Zurich, the company provides FORCES Pro, a numerical optimization software that enables the design of complex control systems. This software is utilized in various applications, including the control of wind turbines, planning the collision-free motion of autonomous drones, and the development of advanced driver assistance systems. Additionally, it supports precision landing of spacecraft on other planets and the recovery of reusable rockets. Embotech's solutions cater to sectors such as automotive, energy, and robotics, aiming to enhance safety, productivity, and energy efficiency in automated decision-making processes. The company is headquartered in Zurich, Switzerland.

Neurosoft Bioelectronics specializes in the development of soft implantable electrodes designed to interface with the nervous system for diagnosing and treating neurological disorders. Based in Geneva, Switzerland, the company has created next-generation electrodes that are compliant and conformable, addressing the limitations of existing stiff devices. Their flagship product, SOFT ECoG, is a subdural electrode that records from and stimulates the brain's surface, enhancing recording quality and minimizing MRI artifacts. Neurosoft's technology promotes long-term bio-integration, adapting to both static and dynamic mechanics of neural tissue, which can improve therapeutic outcomes for patients and expand the applications of neural interfaces in clinical settings.

PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.

Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.

Intelligent Implants specializes in developing wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company provides electrotherapeutic devices that address various diseases and support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants creates innovative, active, and connected medical devices aimed at improving patient treatment and assisting healthcare professionals in their decision-making processes. Founded in 2014 in Cork, the company was established by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer.

SiPearl is a semiconductor company that commercializes the work of the European Processor Initiative (EPI) and bring a low-power microprocessor to market for exascale supercomputing. The company aims to design, market, and distribute its first range of processors with a commercial launch in 2022 based on a roadmap closely aligned with the European Union’s goals. It has already committed to producing its chips using N6 or better processes from TSMC. It was founded in 2019 and headquartered in Maisons-Laffitte, Île-de-France.

Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.

Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.